Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.11
Delayed Data
As of Jan 13
 +0.02 / +0.96%
Today’s Change
1.81
Today|||52-Week Range
3.64
+1.93%
Year-to-Date
3 Reasons Geron Corporation Plunged 57% in 2016
Jan 05 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.09
Today’s open2.09
Day’s range2.06 - 2.14
Volume1,019,956
Average volume (3 months)1,748,287
Market cap$335.8M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...-0.16-1.34%
PTGXProtagonist Therapeu...+0.61+3.22%
XBITXBiotech Inc+0.59+6.25%
ADAPAdaptimmune Therapeu...+0.21+4.86%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs